Quantum Genomics Announces Lack of Significant Efficacy for

Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million...

Related Keywords

Paris ,France General ,France ,New York ,United States ,French ,Catherine Llorens Cortes ,Jean Philippe Milon ,Bruno Besse ,Benoit Gueugnon ,Linkedin ,Twitter ,France French National Institute Of Health ,Scientific Centre For National Research ,Descartes University ,Medical Director ,Quantum Genomics Chief Financial ,Quantum Genomics ,Paris Descartes University ,French National Institute ,Medical Research ,Scientific Centre ,National Research ,Euronext Growth ,Paris Stock Exchange Alqgc ,